End-of-day quote
Korea S.E.
23:00:00 16/05/2024 BST
|
5-day change
|
1st Jan Change
|
6,910
KRW
|
-0.43%
|
|
+4.86%
|
-3.49%
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Capitalization
1 |
60,209
|
83,312
|
187,157
|
337,290
|
185,111
|
190,157
|
Enterprise Value (EV)
1 |
59,840
|
90,153
|
195,567
|
336,338
|
187,617
|
206,994
|
P/E ratio
|
11.8
x
|
282
x
|
125
x
|
76.3
x
|
48.6
x
|
67.8
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.35
x
|
1.9
x
|
4.3
x
|
6.98
x
|
3.25
x
|
4.01
x
|
EV / Revenue
|
1.35
x
|
2.06
x
|
4.49
x
|
6.96
x
|
3.29
x
|
4.36
x
|
EV / EBITDA
|
11.3
x
|
21.9
x
|
45
x
|
46.7
x
|
23.7
x
|
30.2
x
|
EV / FCF
|
29.9
x
|
-7.43
x
|
-28.4
x
|
-67.3
x
|
-83.1
x
|
-14.6
x
|
FCF Yield
|
3.35%
|
-13.5%
|
-3.52%
|
-1.49%
|
-1.2%
|
-6.86%
|
Price to Book
|
1.72
x
|
1.87
x
|
4.06
x
|
6.14
x
|
3.14
x
|
3.08
x
|
Nbr of stocks (in thousands)
|
23,565
|
26,323
|
26,323
|
26,558
|
26,558
|
26,558
|
Reference price
2 |
2,555
|
3,165
|
7,110
|
12,700
|
6,970
|
7,160
|
Announcement Date
|
01/03/19
|
29/02/20
|
01/03/21
|
01/03/22
|
01/03/23
|
29/02/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net sales
1 |
44,435
|
43,771
|
43,540
|
48,295
|
57,025
|
47,464
|
EBITDA
1 |
5,317
|
4,126
|
4,348
|
7,205
|
7,915
|
6,850
|
EBIT
1 |
3,848
|
2,581
|
1,253
|
3,837
|
4,442
|
3,434
|
Operating Margin
|
8.66%
|
5.9%
|
2.88%
|
7.94%
|
7.79%
|
7.23%
|
Earnings before Tax (EBT)
1 |
5,973
|
-190.5
|
940.5
|
4,293
|
3,478
|
900.3
|
Net income
1 |
5,491
|
282.6
|
1,504
|
4,409
|
3,811
|
2,803
|
Net margin
|
12.36%
|
0.65%
|
3.45%
|
9.13%
|
6.68%
|
5.91%
|
EPS
2 |
216.0
|
11.22
|
56.66
|
166.4
|
143.5
|
105.6
|
Free Cash Flow
1 |
2,004
|
-12,136
|
-6,889
|
-4,996
|
-2,258
|
-14,198
|
FCF margin
|
4.51%
|
-27.73%
|
-15.82%
|
-10.34%
|
-3.96%
|
-29.91%
|
FCF Conversion (EBITDA)
|
37.68%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
36.5%
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
01/03/19
|
29/02/20
|
01/03/21
|
01/03/22
|
01/03/23
|
29/02/24
|
Fiscal Period: December |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Net Debt
1 |
-
|
6,840
|
8,410
|
-
|
2,506
|
16,836
|
Net Cash position
1 |
369
|
-
|
-
|
952
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
1.658
x
|
1.934
x
|
-
|
0.3166
x
|
2.458
x
|
Free Cash Flow
1 |
2,004
|
-12,136
|
-6,889
|
-4,996
|
-2,258
|
-14,198
|
ROE (net income / shareholders' equity)
|
16.7%
|
0.7%
|
3.32%
|
8.73%
|
6.69%
|
4.65%
|
ROA (Net income/ Total Assets)
|
4.13%
|
2.43%
|
1.12%
|
2.88%
|
2.88%
|
2.2%
|
Assets
1 |
132,885
|
11,649
|
133,931
|
153,273
|
132,254
|
127,568
|
Book Value Per Share
2 |
1,486
|
1,692
|
1,749
|
2,070
|
2,220
|
2,323
|
Cash Flow per Share
2 |
89.30
|
172.0
|
195.0
|
199.0
|
318.0
|
378.0
|
Capex
1 |
4,395
|
15,052
|
7,368
|
5,552
|
3,786
|
16,903
|
Capex / Sales
|
9.89%
|
34.39%
|
16.92%
|
11.5%
|
6.64%
|
35.61%
|
Announcement Date
|
01/03/19
|
29/02/20
|
01/03/21
|
01/03/22
|
01/03/23
|
29/02/24
|
|
1st Jan change
|
Capi.
|
---|
| -3.49% | 136M | | +17.80% | 66.73B | | +2.92% | 49.79B | | +19.98% | 42.5B | | +20.88% | 26.45B | | +12.04% | 19.66B | | +1.27% | 17.18B | | -22.98% | 15.82B | | +2.77% | 15.56B | | -9.25% | 15.41B |
Other Specialty Chemicals
|